Conflict of interest [GxP / QC / QA]

posted by Helmut Homepage – Vienna, Austria, 2018-01-16 13:45 (2348 d 10:29 ago) – Posting: # 18180
Views: 4,187

Hi Norah,

❝ In the case that a pharmaceutical company has it own BE center (like Apotex), how is it possible to avoid COI when performing BE studies for it's own drugs?


You certainly have a point! In such a case the pressure to deliver “favorable” results might be even larger than usual…

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,059 posts in 4,841 threads, 1,663 registered users;
29 visitors (0 registered, 29 guests [including 5 identified bots]).
Forum time: 01:14 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5